| 18F-FDG PET and PET/CT in the evaluation of cancer treatment response. | |
| | |
MedLine Citation:
|
PMID: 19139187 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Multimodality imaging, as represented by its greatest exponent, PET/CT, has a firm place in the evaluation of a patient presenting with cancer. With 18F-FDG, PET/CT is rapidly becoming the key investigative tool for the staging and assessment of cancer recurrence. In the last 5 y, PET/CT has also gained widespread acceptance as a key tool used to demonstrate early response to intervention and therapy. In this setting, a major clinical need is being addressed with 18F-FDG PET/CT, because of its inherent ability to demonstrate (before other markers of response) if disease modification has occurred. This review presents available evidence to this effect. |
| | |
Authors:
|
Simona Ben-Haim; Peter Ell |
Related Documents
:
|
18243447 - Role of tonsillectomy in the search for a squamous cell carcinoma from an unknown prima... 15912427 - Clinical value of combined positron emission tomography/computed tomography imaging in ... 11150767 - 10. positron emission tomography in the presurgical evaluation of patients with resecta... 17275167 - Molecular positron emission tomography and pet/ct imaging in urological malignancies. 6867357 - Hydrocephalus in adults. ultrasound detection through surgically created cranial defects. 14765137 - Noninvasive assessment of the injured human spinal cord by means of functional magnetic... |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Journal of nuclear medicine : official publication, Society of Nuclear Medicine Volume: 50 ISSN: 0161-5505 ISO Abbreviation: J. Nucl. Med. Publication Date: 2009 Jan |
Date Detail:
|
Created Date: 2009-01-13 Completed Date: 2009-03-06 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0217410 Medline TA: J Nucl Med Country: United States |
Other Details:
|
Languages: eng Pagination: 88-99 Citation Subset: IM |
Affiliation:
|
Institute of Nuclear Medicine, University College London, and University College London Hospital, London, United Kingdom. Simona.ben-haim@uclh.nhs.uk |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Fluorodeoxyglucose F18
/
diagnostic use* Humans Neoplasms / radiography*, radionuclide imaging*, therapy Positron-Emission Tomography / methods* Tomography, X-Ray Computed / methods* Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
63503-12-8/Fluorodeoxyglucose F18 |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Phase II trial of estramustine phosphate and oral etoposide in patients with hormone-refractory pros...
Next Document: Spatial resolution and sensitivity of the Inveon small-animal PET scanner.